Good morning and welcome to the start of another week. Here is what I am reading as we kick off the final week in June:
- How CRISPR Gene Editing Is Revolutionizing Medicine And The Companies Who Invest In It
- Targeting cancer cells’ escape vehicles to stop tumor metastasis
- Does your clinical trial policy include coverage for “failure to supply?” With the supply chain being stretched how vulnerable is your company to key suppliers? – Drug shortages again on the rise after 5 years of improvements, FDA says
- 11 Biotech Stock events to watch next week; Biotech week in review
MattCorc 